ICC Holdings, Inc. Reports 2022 First Quarter Results
FIRST QUARTER ENDED
Direct premiums written grew by
Net loss totaled
For the first quarter of 2022, the Company ceded to reinsurers
Net investment income increased by
Losses and settlement expenses increased by
Policy acquisition costs and other operating expenses increased by
Total assets decreased by 0.7% from
FIRST QUARTER ENDED
The Company's losses and settlement expense ratio (defined as losses and settlement expenses divided by net premiums earned) was 63.7% for the first quarter compared with 64.8% for the same period of 2021.
The expense ratio (defined as the amortization of deferred policy acquisition costs and underwriting and administrative expenses divided by net premiums earned) was 36.0% for the first quarter compared to 37.1% for the same period of 2021.
The Company's GAAP combined ratio (defined as the sum of the losses and settlement expense ratio and the expense ratio) was 99.7% for the first quarter compared to 101.8% for the same period of 2021.
MANAGEMENT COMMENTARY
"We are very pleased with generating positive operating results thus far in 2022. The first quarter's premium writings have set the stage for another exciting year, outpacing a typical first quarter by about 20%. The focus has been on retaining business of existing policyholders and ensuring the Company has adequate renewal rates to support future loss experience.
"Our positive growth in quality insurance policies continues to be instrumental in reducing our loss ratio as demonstrated in the first quarter compared to the same quarter last year. The equity and bond market declines experienced by the insurance industry, outpaced the Company's first quarter profits. As the markets continue to react to inflationary pressures, we are committed to maintaining investment portfolio diversity and exploring new investment property opportunities.
"The Company's geographic expansion efforts have gained traction and a selected handful of potential new states are currently undergoing a healthy dose of scrutiny. We are positioned to provide ICC expertise to more policyholders in the coming year," stated
ABOUT
The Company's common shares trade on the NASDAQ Capital Market under the ticker symbol "ICCH". For more information about
FORWARD-LOOKING STATEMENTS
This press release, and oral statements made regarding the subjects of this release, contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, or the Reform Act, which may include, but are not limited to, statements regarding the Company's, plans, objectives, expectations, and intentions and other statements contained in this press release that are not historical facts, including statements identified by words such as "believe," "plan," "seek," "expect," "intend," "estimate," "anticipate," "will," and similar expressions. All statements addressing operating performance, events, or developments that the Company expects or anticipates will occur in the future, including statements relating to revenue and profit growth; future responses to and effects of the COVID-19 pandemic, as well the distribution and effectiveness of COVID-19 vaccines, including their effects on our business operations and claims activity; new theories of liability; judicial, legislative, regulatory and other governmental developments, including, but not limited to, liability related to business interruption claims related to COVID-19; litigation tactics and developments; product and segment expansion; regulatory approval in connection with expansion; downturns and volatility in global economies and equity and credit markets, including as a result of inflation and supply chain disruptions and continued labor shortages; interest rates and changes in rates could adversely affect the Company's business and profitability; and market share, as well as statements expressing optimism or pessimism about future operating results, are forward-looking statements within the meaning of the Reform Act. The forward-looking statements are based on management's current views and assumptions regarding future events and operating performance, and are inherently subject to significant business, economic, and competitive uncertainties and contingencies and changes in circumstances, many of which are beyond the Company's control. The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not undertake any obligation to update or revise these statements to reflect events or circumstances occurring after the date of this press release.
Although the Company does not make forward-looking statements unless it believes it has a reasonable basis for doing so, the Company cannot guarantee their accuracy. The foregoing factors, among others, could cause actual results to differ materially from those described in these forward-looking statements. For a list of other factors which could affect the Company's results, see the Company's filings with the
|
||||||||||||
Condensed Consolidated Balance Sheets |
||||||||||||
As of |
||||||||||||
|
|
|||||||||||
2022 |
2021 |
|||||||||||
(Unaudited) |
||||||||||||
Assets |
||||||||||||
Investments and cash: |
||||||||||||
Fixed maturity securities (amortized cost of |
$ |
101,872,420 |
$ |
105,841,543 |
||||||||
Common stocks at fair value |
22,795,115 |
23,608,197 |
||||||||||
Preferred stocks at fair value |
2,858,036 |
2,780,450 |
||||||||||
Other invested assets |
3,175,674 |
3,086,568 |
||||||||||
Property held for investment, at cost, net of accumulated depreciation of |
5,871,484 |
5,509,114 |
||||||||||
Cash and cash equivalents |
4,580,287 |
4,606,378 |
||||||||||
Total investments and cash |
141,153,016 |
145,432,250 |
||||||||||
Accrued investment income |
726,561 |
659,413 |
||||||||||
Premiums and reinsurance balances receivable, net of allowances for |
27,410,129 |
27,199,804 |
||||||||||
Ceded unearned premiums |
948,000 |
967,022 |
||||||||||
Reinsurance balances recoverable on unpaid losses and settlement expenses, |
16,088,694 |
14,521,219 |
||||||||||
Federal income taxes |
631,825 |
195,694 |
||||||||||
Deferred policy acquisition costs, net |
7,156,770 |
6,538,844 |
||||||||||
Property and equipment, at cost, net of accumulated depreciation of |
3,189,728 |
3,144,218 |
||||||||||
Other assets |
1,305,288 |
1,343,504 |
||||||||||
Total assets |
$ |
198,610,011 |
$ |
200,001,968 |
||||||||
Liabilities and Equity |
||||||||||||
Liabilities: |
||||||||||||
Unpaid losses and settlement expenses |
$ |
67,407,376 |
$ |
61,834,809 |
||||||||
Unearned premiums |
37,509,068 |
36,212,266 |
||||||||||
Reinsurance balances payable |
503,656 |
1,368,294 |
||||||||||
Corporate debt |
18,452,288 |
18,455,342 |
||||||||||
Accrued expenses |
4,174,785 |
5,441,611 |
||||||||||
Income taxes - deferred |
— |
954,862 |
||||||||||
Other liabilities |
872,609 |
1,030,870 |
||||||||||
Total liabilities |
128,919,782 |
125,298,054 |
||||||||||
Equity: |
||||||||||||
Common stock1 |
35,000 |
35,000 |
||||||||||
Treasury stock, at cost2 |
(3,122,492) |
(3,155,399) |
||||||||||
Additional paid-in capital |
32,989,963 |
32,965,136 |
||||||||||
Accumulated other comprehensive earnings, net of tax |
(2,049,042) |
2,920,027 |
||||||||||
Retained earnings |
44,122,755 |
44,282,895 |
||||||||||
Less: Unearned Employee Stock Ownership Plan shares at cost3 |
(2,285,955) |
(2,343,745) |
||||||||||
Total equity |
69,690,229 |
74,703,914 |
||||||||||
Total liabilities and equity |
$ |
198,610,011 |
$ |
200,001,968 |
1Par value |
22022 –206,189 shares and 2021 –208,875 shares |
32022 –228,595 shares and 2021 –234,374 shares |
|
||||||
Condensed Consolidated Statements of Earnings and Comprehensive Earnings (Unaudited) |
||||||
For the Three-Months Ended |
||||||
|
||||||
2022 |
2021 |
|||||
Net premiums earned |
$ |
16,016,677 |
$ |
12,048,713 |
||
Net investment income |
917,081 |
801,406 |
||||
Net realized investment gains |
207,585 |
186,709 |
||||
Net unrealized (losses) gains on equity securities |
(1,292,692) |
876,316 |
||||
Other income |
159,431 |
46,716 |
||||
Consolidated revenues |
16,008,082 |
13,959,860 |
||||
Losses and settlement expenses |
10,195,201 |
7,802,706 |
||||
Policy acquisition costs and other operating expenses |
5,772,400 |
4,467,578 |
||||
Interest expense on debt |
61,011 |
53,702 |
||||
General corporate expenses |
189,415 |
163,982 |
||||
Total expenses |
16,218,027 |
12,487,968 |
||||
(Loss) earnings before income taxes |
(209,945) |
1,471,892 |
||||
Total income tax (benefit) expense |
(49,805) |
309,951 |
||||
Net (loss) earnings |
$ |
(160,140) |
$ |
1,161,941 |
||
Other comprehensive loss, net of tax |
(4,969,069) |
(2,226,522) |
||||
Comprehensive loss |
$ |
(5,129,209) |
$ |
(1,064,581) |
||
Earnings per share: |
||||||
Basic: |
||||||
Basic net (loss) earnings per share |
$ |
(0.05) |
$ |
0.38 |
||
Diluted: |
||||||
Diluted net (loss) earnings per share |
$ |
(0.05) |
$ |
0.38 |
||
Weighted average number of common shares outstanding: |
||||||
Basic |
3,060,208 |
3,034,233 |
||||
Diluted |
3,072,176 |
3,044,479 |
||||
Contact Info:
(309) 732-0105
[email protected]
225 20th Street,
View original content:https://www.prnewswire.com/news-releases/icc-holdings-inc-reports-2022-first-quarter-results-301543282.html
SOURCE
Studies from University of Nigeria Have Provided New Data on Health Economics [Evaluating a capacity development intervention in health economics among producers and users of evidence in Nigeria: a case study in Getting Research Into Policy and …]: Economics – Health Economics
May 10, 2022 | Media relations
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News